通过叶酸受体的双膜受体降解,以奇美拉为目标
Zhen Wang1, Zhixin Li2,3, Jenny Högström4
1Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Nature communications
|October 2, 2025
概括
设计的双降解剂,叶酸受体α向奇梅拉-双 (FolTAC-双),通过同时降解EGFR/HER2和PD-L1/VISTA等受体对来克服癌症药物耐药性,显示出临床翻译的希望.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物开发 药物开发
背景情况:
- 抗癌药物耐药性是一个重大的临床挑战,通常是由涉及膜结合受体的复杂信号通路驱动的.
- 目前的单一向疗法经常受到受体交叉谈话的影响,导致治疗失败.
研究的目的:
- 开发一种新的双膜受体降解策略,以克服癌症药物耐药性.
- 为了设计叶酸受体α 向奇梅拉-双 (FolTAC-双) 以同时降解特定的受体对.
主要方法:
- 设计和优化FolTAC双构造,确定"字符串"格式是最有效的.
- 使用机理学研究调查结合亲和力和降解效率.
- 在HER2阳性乳腺癌和免疫检查点阻塞抵抗的临床前模型中评估疗效.
主要成果:
- 与传统设计相比,FolTAC-dual表现出增强的EGFR结合亲和力.
- 在HER2阳性乳腺癌模型中,EGFR/HER2 FolTAC-dual有效抵消了耐药性.
- 在耐药模型中,PD-L1/VISTA FolTAC双重恢复了免疫反应.
结论:
- FolTAC-dual代表了一种有前途的平台,用于对抗癌症药物耐药性的双目标降解.
- 这一策略有可能在各种瘤学环境中进行临床转化.
相关概念视频
Receptor Downregulation in MVBs
2.8K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.8K
Export of Misfolded Proteins out of the ER
5.0K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
5.0K
Receptor-mediated Endocytosis
110.5K
Overview
110.5K
Receptor-mediated Endocytosis
7.5K
Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
7.5K
GPCR Desensitization
7.9K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.9K
Mitochondrial Precursor Proteins
3.6K
Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70 chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial...
Most of the mitochondrial...
3.6K


